Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR







DALLAS, Jan. 18, 2024 /PRNewswire/ — “We are today announcing the second phase of our global marketing campaign of the historic Turkey Track Ranch, with a list price of $180 million dollars. This includes a 25% ownership stake within a near- 100% mineral ownership holding,” stated Bernard Uechtritz of Icon Global.

The basis of the offering price comes from updated independent valuation analyses recently completed by two nationally renowned appraisal firms, providing a data-driven range of fair market value, with and without mineral ownership. Farm lending specialist, Capital Farm Credit, is positioned to underwrite buyer financing.

In addition to the appraisal process, owners have engaged with third parties evaluating additional factors and opportunities of the Ranch. These range from various conservation proposals—from carbon sequestration and new energy initiatives such as wind and solar, to water initiatives.  Additionally, there is potential for further development of oil and gas via new technologies. A significant portion of the property remains unexplored relative to hydrocarbon prospects.

Jonathan Grammer of U.S. Carbon Capture said, “Our team has spent two years analyzing the subsurface geology of the Turkey Track Ranch and believes the potential for long-term carbon sequestration and its lucrative revenue stream is one of the best in the Texas Panhandle.  Its proximity to carbon dioxide emitters combined with the unique storage zones of the Anadarko Basin, which lay beneath it, make this 80,000-acre jewel a strong candidate. In addition, because of our work, we believe shallower undeveloped zones may exist as well for future oil and gas development.”

 “Our stakeholders are all generational beneficiaries,” says Kim McTee, a third- generation Coble family descendant and one of five managers of the ownership trust. “The collective decision to sell, naturally, contains mixed emotions,” McTee further acknowledges, “There are some, who in a perfect world, would hope to explore the option of a percentage of retained ownership. Others prefer to liquidate their interests in the sale, which is typical of large ranching families that have expanded over successive generations. Our process has been one of patience and respect for our foundational history together, with a sincere search for the appropriate steward. We were recently presented with an innovative concept incorporating a co-ownership model within our first round of offers, and we continue to explore this option. Expressions of interest continue and include conservation initiatives, even ideas for the reintroduction of buffalo to the plains area via the ranch are under evaluation. Concurrently, we are proceeding with the second phase of our marketing campaign, as we explore, invite and advance opportunity.”

Concept Elemental’s Jennifer Warren has studied and analyzed the property.  From her natural capital lens and approach, she notes: “The natural assets of the ranch have been meticulously curated and improved across the decades, where modern practices and technology have been applied, even pioneered. Through conservation-oriented dams, riparian micro-sanctuaries, and systems which support native grasslands, wildlife, and soil health, the Turkey Track Ranch portrays the very essence of natural capital. The ranch’s generational stewards—notably including the strong leadership of women—have protected and served the interests of the land and those connected to it. The preservation of the resources of the Turkey Track Ranch, its natural capital, makes it an unimpeachable national treasure.”

Uechtritz conveys: “As we continue consideration for a legacy buyer, our campaign has also attracted institutional and conservation interest around various ESG initiatives.” Today, there is no shortage of firms like Morgan Stanley, BlackRock, Deloitte, and others who look to fulfill ESG mandates directly as well as via natural asset companies (NACs). This is an increasingly active and opportunistic market in the rapidly advancing environmental finance and investment space connected to the ranching asset class. Organization’s such as The Rockefeller Foundation, along with conduits such as the Intrinsic Exchange Group, have been advancing investment from both private and public sectors into such initiatives.

“That said, this sale offering is not a matter of if, or how, but when and to whom,” Uechtritz concludes.

About the TTR

The Turkey Track Ranch is a stand-alone offering—one of the last great legacy ranch opportunities in Texas. It is rich in history and is a cache of natural capital. The ranch provides an array of opportunities in the development of its natural resources, as well as enhancements of its existing recreation, hunting, and cattle herd operations. There are tremendous potential hospitality and conservation initiatives tied to its incredible and unique position in history, while retaining the stewardship values from its tremendous brand and legacy factors.”

About Icon Global

Icon Global designs and implements strategic, tactical marketing and sales campaigns for unique, high-end properties globally.  Icon Global was founded by complex deal maker and International real estate advisor, Bernard Uechtritz.  The Australian native most notably led the global marketing and sale of the 535,000 acre W.T. Waggoner Ranch in Vernon, Texas, listed at $725 million, the largest ranch in North America under one contiguous fence, in a world record sale that still stands today.

Target URL – TTR webpage (videos, photos, story, info): 

TTR digital book

TTR story – (Icon Global owned. Use permitted)

TTR – photos – (photo credits listed per file)

TTR video links:
Turkey Track Ranch – Official Launch Feature Video

Icon Global Flying the Turkey Track

Turkey Track Ranch – Global Preview

TTR – Google Search – News Links

Logo –

Cision View original content:–gas-ownership-stake-80-000-acre-landmark-is-epitome-of-asset-class-surrounding-natural-capital-302037447.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading